Ardelyx Inc. (ARDX)

2.99 +0.06 (+2.048%)

IEX Real-Time Price

November 16, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 2.93

Price Open 2.88

Volume: 236,573

Avg Volume: 303,443

Market Cap: 185.78M

P/E Ratio -3.11

52 Wk Range 2.53-8.1



ARDX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
59.86M
605,453
1.97
1.01%

2018-09-28
59.86M
761,868
2.08
1.27%

2018-09-14
59.86M
547,358
1.60
0.91%

2018-08-31
59.86M
556,922
1.74
0.93%




ARDX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-07
Q3 2018
N/A
-0.41 (3)
-0.39
0.02

2018-08-07
Q2 2018
AMC
-0.41 (2)
-0.42
-0.01

2018-05-08
Q1 2018
N/A
-0.42 (2)
-0.36
0.06

2018-05-04
Q1 2018
N/A
-0.40 (2)
0.00
0.00

News

Ardelyx Announces FDA Acceptance of the Filing of its New Drug Application for Tenapanor for the Treatment of Patients with IBS-C (2018-11-13 08:30 PR Newswire)

FREMONT, Calif. , Nov. 13, 2018 /PRNewswire/ --Ardelyx, Inc. (Nasdaq: ARDX), today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tenapanor for the treatment of patients with irritable bowel syndrome with c…

 


Statistics

Shares Outstanding: 62.13M

Top 15 Institution Percent: 64.10

Price To Sales: 4.11

Price To Book: 1.29

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -30.49

Return On Equity: -39.78

Profit Margin: N/A

Price History

Beta: 1.34

50-day Moving Avg: 3.65

200-day Moving Avg: 4.48

YTD Change: -57.29

5-day Change: 1.36

1-month Change: -24.87

3-month Change: -27.07

6-month Change: -47.54

1-year Change: -46.61

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Ardelyx Inc.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.ardelyx.com

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases.